Relatrilfa-α
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Relatrilfa-α, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Relatrilfa-α Plus Single-Agent Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III NSCLC (Phase 2) [Phase 2]